<< Updates on diastology and new and emerging echo technologies | Spinal implants market to grow in the coming years: iData Research >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | العربية | Nederlands | Русский | Svenska | Polski

Genoptix to present an overview of its specialized diagnostic laboratory services business

Published on September 14, 2009 at 8:22 AM · No Comments

Genoptix, Inc. (Nasdaq: GXDX), a specialized laboratory services provider, today announced the Company's participation at the following upcoming investor conferences:

On Monday, September 21, 2009, Genoptix COO, Sam Riccitelli, will present at the Bank of America Merrill Lynch Smid Cap Conference at the InterContinental Hotel in Boston, Mass. The presentation will begin at 3:20 p.m. EDT and is expected to last approximately 40 minutes.

On Tuesday, September 22, 2009, Mr. Riccitelli will present at the UBS Global Life Science Conference at the Grand Hyatt in New York City. The presentation is scheduled to begin at 8:30 a.m. EDT, is expected to last approximately 30 minutes and will be followed by a 30 minute break-out session.

Mr. Riccitelli will provide an overview of the Company's specialized diagnostic laboratory services business, growth strategies and financial performance at each of the presentations, which will be web cast live and made accessible through the "Investors" section of the Genoptix website at www.genoptix.com. Those who would like to listen to these presentations should go to this site at least 15 minutes prior to each event to register, download and install any necessary software. A replay will also be available for 30 days following each initial presentation web cast.

Source: http://www.genoptix.com

Posted in:

Tags: , , ,

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading